ARTICLE | Company News
Cytokine other research news
July 27, 1998 7:00 AM UTC
Cytokine Networks received a $100,000 Phase I SBIR from the National Cancer Institute to study the role of fibrocytes as a potential cancer vaccine. The cells are as potent as dendritic cells in gener...